GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Price-to-Owner-Earnings

Haleon (Haleon) Price-to-Owner-Earnings : 19.62 (As of May. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Price-to-Owner-Earnings?

As of today (2024-05-12), Haleon's share price is $8.24. Haleon's Owner Earnings per Share (TTM) ended in Dec. 2023 was $0.42. It's Price-to-Owner-Earnings for today is 19.62.


The historical rank and industry rank for Haleon's Price-to-Owner-Earnings or its related term are showing as below:

HLN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.8   Med: 19.43   Max: 19.97
Current: 19.4

During the past 5 years, the highest Price-to-Owner-Earnings of Haleon was 19.97. The lowest was 18.80. And the median was 19.43.


HLN's Price-to-Owner-Earnings is ranked better than
64.68% of 419 companies
in the Drug Manufacturers industry
Industry Median: 27.85 vs HLN: 19.40

As of today (2024-05-12), Haleon's share price is $8.24. Haleon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30. Therefore, Haleon's PE Ratio for today is 27.84.

As of today (2024-05-12), Haleon's share price is $8.24. Haleon's EPS without NRI for the trailing twelve months (TTM) ended in was $0.29. Therefore, Haleon's PE Ratio without NRI for today is 28.03.

During the past 5 years, Haleon's highest PE Ratio without NRI was 29.61. The lowest was 10.47. And the median was 12.16.


Haleon Price-to-Owner-Earnings Historical Data

The historical data trend for Haleon's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Price-to-Owner-Earnings Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - 19.14

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 19.14 -

Competitive Comparison of Haleon's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Haleon's Price-to-Owner-Earnings falls into.



Haleon Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Haleon's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=8.24/0.42
=19.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon  (NYSE:HLN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Haleon Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Haleon's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (Haleon) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.